135 related articles for article (PubMed ID: 3032256)
1. Quinidine and melittin both decrease the fluidity of liver plasma membranes and both inhibit hormone-stimulated adenylate cyclase activity.
Needham L; Dodd NJ; Houslay MD
Biochim Biophys Acta; 1987 May; 899(1):44-50. PubMed ID: 3032256
[TBL] [Abstract][Full Text] [Related]
2. Dimethylnitrosamine inhibits the glucagon-stimulated adenylate cyclase activity of rat liver plasma membranes and decreases plasma membrane fluidity.
Whetton AD; Needham L; Margison GP; Dodd NJ; Houslay MD
Biochim Biophys Acta; 1984 Jun; 773(1):106-12. PubMed ID: 6329276
[TBL] [Abstract][Full Text] [Related]
3. Perturbations of liver plasma membranes induced by Ca2+ are detected using a fatty acid spin label and adenylate cyclase as membrane probes.
Gordon LM; Whetton AD; Rawal S; Esgate JA; Houslay MD
Biochim Biophys Acta; 1983 Mar; 729(1):104-14. PubMed ID: 6299344
[TBL] [Abstract][Full Text] [Related]
4. Changes in the form of Arrhenius plots of the activity of glucagon-stimulated adenylate cyclase and other hamster liver plasma-membrane enzymes occurring on hibernation.
Houslay MD; Palmer RW
Biochem J; 1978 Sep; 174(3):909-19. PubMed ID: 728095
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-stimulated adenylate cyclase detects a selective perturbation of the inner half of the liver plasma-membrane bilayer achieved by the local anaesthetic prilocaine.
Houslay MD; Dipple I; Rawal S; Sauerheber RD; Esgate JA; Gordon LM
Biochem J; 1980 Jul; 190(1):131-7. PubMed ID: 6255940
[TBL] [Abstract][Full Text] [Related]
6. The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment.
Dipple I; Houslay MD
Biochem J; 1978 Jul; 174(1):179-90. PubMed ID: 697751
[TBL] [Abstract][Full Text] [Related]
7. Acidic phospholipid species inhibit adenylate cyclase activity in rat liver plasma membranes.
Houslay MD; Needham L; Dodd NJ; Grey AM
Biochem J; 1986 Apr; 235(1):237-43. PubMed ID: 3741383
[TBL] [Abstract][Full Text] [Related]
8. Elevated membrane cholesterol concentrations inhibit glucagon-stimulated adenylate cyclase.
Whetton AD; Gordon LM; Houslay MD
Biochem J; 1983 Feb; 210(2):437-49. PubMed ID: 6305341
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase and a fatty acid spin probe detect changes in plasma membrane lipid phase separations induced by dietary manipulation of the cholesterol:phospholipid ratio.
Needham L; Finnegan I; Houslay MD
FEBS Lett; 1985 Apr; 183(1):81-6. PubMed ID: 2984051
[TBL] [Abstract][Full Text] [Related]
10. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
[TBL] [Abstract][Full Text] [Related]
11. Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity.
Whetton AD; Needham L; Dodd NJ; Heyworth CM; Houslay MD
Biochem Pharmacol; 1983 May; 32(10):1601-8. PubMed ID: 6305364
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membranes.
Houslay MD; Dipple I; Gordon LM
Biochem J; 1981 Sep; 197(3):675-81. PubMed ID: 7325977
[TBL] [Abstract][Full Text] [Related]
13. Effects of temperature and benzyl alcohol on the structure and adenylate cyclase activity of plasma membranes from bovine adrenal cortex.
de Foresta B; Rogard M; le Maire M; Gallay J
Biochim Biophys Acta; 1987 Dec; 905(2):240-56. PubMed ID: 2825779
[TBL] [Abstract][Full Text] [Related]
14. Adenylate cyclase is inhibited upon depletion of plasma-membrane cholesterol.
Whetton AD; Gordon LM; Houslay MD
Biochem J; 1983 May; 212(2):331-8. PubMed ID: 6309140
[TBL] [Abstract][Full Text] [Related]
15. Melittin stimulates incorporation and degradation of sphingomyelin in synaptosomal plasma membranes.
Pellkofer R; Marsh D; Hoffmann-Bleihauer P; Sandhoff K
J Neurochem; 1982 May; 38(5):1230-5. PubMed ID: 6278088
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes.
Gerst JE; Salomon Y
Endocrinology; 1987 Nov; 121(5):1766-72. PubMed ID: 3665846
[TBL] [Abstract][Full Text] [Related]
17. Effect of melittin-induced membrane alterations on rat heart adenylate cyclase activity.
Lad PL; Shier WT
Arch Biochem Biophys; 1980 Oct; 204(2):418-24. PubMed ID: 6255869
[No Abstract] [Full Text] [Related]
18. Arrhenius plot characteristics of adipocyte-plasma-membrane adenylate cyclase activity in lean and genetically obese (ob/ob) mice.
French RR; York DA
Biosci Rep; 1984 Dec; 4(12):1001-8. PubMed ID: 6099153
[TBL] [Abstract][Full Text] [Related]
19. The activity of dopamine-stimulated adenylate cyclase from rat brain stratum is modulated by temperature and the bilayer-fluidizing agent, benzyl alcohol.
Needham L; Houslay MD
Biochem J; 1982 Jul; 206(1):89-95. PubMed ID: 7126197
[TBL] [Abstract][Full Text] [Related]
20. Melittin interactions with adenylate cyclase.
Cook GH; Wolff J
Biochim Biophys Acta; 1977 Jun; 498(1):255-8. PubMed ID: 884154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
